Wargacki Stephen has filed 12 insider transactions across 1 company since March 2023.
Most recent transaction: a tax payment of 4572 shares of Aquestive Therapeutics, Inc. ($AQST) on March 10, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 10, 2025 | Aquestive Therapeutics, Inc. | $AQST | Wargacki Stephen | Chief Science Officer | F | Common Stock | 4572 | $2.54 | 343,552.0000 | 98,871,369 | 1.31% | 0.00% |
| March 7, 2025 | Aquestive Therapeutics, Inc. | $AQST | Wargacki Stephen | Chief Science Officer | F | Common Stock | 12859 | $2.65 | 363,555.0000 | 98,871,369 | 3.42% | 0.01% |
| March 9, 2025 | Aquestive Therapeutics, Inc. | $AQST | Wargacki Stephen | Chief Science Officer | F | Common Stock | 15431 | $2.65 | 348,124.0000 | 98,871,369 | 4.24% | 0.02% |
| March 7, 2025 | Aquestive Therapeutics, Inc. | $AQST | Wargacki Stephen | Chief Science Officer | A | Non-Qualified Stock Option (right to buy) | 65000 | $0.00 | 65,000.0000 | 98,871,369 | 9999.99% | 0.07% |
| March 7, 2025 | Aquestive Therapeutics, Inc. | $AQST | Wargacki Stephen | Chief Science Officer | A | Common Stock | 115000 | $0.00 | 376,414.0000 | 98,871,369 | 43.99% | 0.12% |
| March 9, 2024 | Aquestive Therapeutics, Inc. | $AQST | Wargacki Stephen | Chief Science Officer | F | Common Stock | 19505 | $4.88 | 261,414.0000 | 0 | 6.94% | 0.00% |
| May 10, 2024 | Aquestive Therapeutics, Inc. | $AQST | Wargacki Stephen | Chief Science Officer | A | Common Stock | 10000 | $0.00 | 267,963.0000 | 0 | 3.88% | 0.00% |
| March 10, 2024 | Aquestive Therapeutics, Inc. | $AQST | Wargacki Stephen | SVP, Research & Development | F | Common Stock | 1687 | $4.88 | 257,963.0000 | 0 | 0.65% | 0.00% |
| March 9, 2024 | Aquestive Therapeutics, Inc. | $AQST | Wargacki Stephen | SVP, Research & Development | F | Common Stock | 11269 | $4.88 | 259,650.0000 | 0 | 4.16% | 0.00% |
| March 7, 2024 | Aquestive Therapeutics, Inc. | $AQST | Wargacki Stephen | SVP, Research & Development | A | Common Stock | 112500 | $0.00 | 270,919.0000 | 0 | 71.01% | 0.00% |
| March 10, 2023 | Aquestive Therapeutics, Inc. | $AQST | Wargacki Stephen | SVP, Research & Development | F | Common Stock | 1981 | $0.79 | 158,419.0000 | 0 | 1.24% | 0.00% |
| March 7, 2024 | Aquestive Therapeutics, Inc. | $AQST | Wargacki Stephen | SVP, Research & Development | A | Non-Qualified Stock Option (right to buy) | 56250 | $0.00 | 56,250.0000 | 0 | 9999.99% | 0.00% |